[Intravascular large B-cell lymphoma; recent advances and future perspectives].
Shimada
Kazuyuki
K
Naoe
Tomoki
T
Nakamura
Shigeo
S
Kinoshita
Tomohiro
T
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000276:immunology / Q000473:pathology / Q000628:therapy; D000069283:Rituximab; D015996:Survival Rate; D019043:Vascular Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000473:pathology / Q000628:therapy
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab